Anika is a biomedical joint preservation company that leverages proprietary regenerative and restoration therapies to help people feel better faster and remain active. For nearly 30 years and 35 million procedures worldwide, Anika has been passionately advancing quality patient care by enabling people to continue doing what they love.
51 to 200Type
Company - Public (ANIK)Revenue
$100 to $500 million (USD) per yearIndustry
Biotech & PharmaceuticalsCompetitors